Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

NCT00001565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Brain Neoplasms
Neuroblastoma

Interventions

DRUG: phenylbutyrate

Sponsor

National Cancer Institute (NCI)